Piper Sandler analyst Jessica Tassan lowered the price target on Phreesia Inc. (NYSE: PHR) to $23.00 (from $34.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Phreesia Inc. (PHR) PT Lowered to $20 at StephensMarch 31, 2026 7:05 AM Phreesia Inc. (PHR) PT Lowered to $14 at Needham, 'Buyers at these depressed levels'March 31, 2026 6:26 AM Phreesia Inc. (PHR) PT Lowered to $22 at CanaccordMarch 31, 2026 6:26 AM Phreesia Inc. (PHR) PT Lowered to $19 at RBC CapitalMarch 31, 2026 6:22 AM Phreesia sinks 26% after substantial outlook cut; Wall Street downgrades sharesMarch 31, 2026 5:54 AM RBC Cautious on Phreesia Inc. (PHR): 'we will be listening for further color on any potential for improved visibility into pharma marketing spending'March 31, 2026 5:41 AM Citi Downgrades Phreesia Inc. (PHR) to NeutralMarch 31, 2026 3:10 AM JPMorgan Downgrades Phreesia Inc. (PHR) to NeutralMarch 31, 2026 2:14 AM Truist Securities Downgrades Phreesia Inc. (PHR) to HoldMarch 31, 2026 2:11 AM Baird Downgrades Phreesia Inc. (PHR) to NeutralMarch 31, 2026 2:11 AM